210 related articles for article (PubMed ID: 36228378)
1. Drug repurposing - A search for novel therapy for the treatment of diabetic neuropathy.
Paul A; Kumar M; Das P; Guha N; Rudrapal M; Zaman MK
Biomed Pharmacother; 2022 Dec; 156():113846. PubMed ID: 36228378
[TBL] [Abstract][Full Text] [Related]
2. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
Iyer S; Sam FS; DiPrimio N; Preston G; Verheijen J; Murthy K; Parton Z; Tsang H; Lao J; Morava E; Perlstein EO
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31636082
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of Nrf-2 pathway in the treatment of diabetic neuropathy and nephropathy.
Gupta A; Behl T; Sehgal A; Bhatia S; Jaglan D; Bungau S
Mol Biol Rep; 2021 Mar; 48(3):2761-2774. PubMed ID: 33754251
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and current treatment options for diabetic neuropathies.
Casellini CM; Vinik AI
Endocr Pract; 2007 Sep; 13(5):550-66. PubMed ID: 17872358
[TBL] [Abstract][Full Text] [Related]
5. Diabetic peripheral neuropathy: current perspective and future directions.
Singh R; Kishore L; Kaur N
Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831
[TBL] [Abstract][Full Text] [Related]
6. Diabetic neuropathy.
Smith AG; Singleton JR
Continuum (Minneap Minn); 2012 Feb; 18(1):60-84. PubMed ID: 22810070
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review.
Sher EK; Džidić-Krivić A; Karahmet A; Beća-Zećo M; Farhat EK; Softić A; Sher F
Diabetes Metab Syndr; 2023 Nov; 17(11):102901. PubMed ID: 37951098
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum and diagnosis of diabetic neuropathies.
Oh J
Korean J Intern Med; 2020 Sep; 35(5):1059-1069. PubMed ID: 32921007
[TBL] [Abstract][Full Text] [Related]
9. Current advancement in the preclinical models used for the assessment of diabetic neuropathy.
Saini T; Mazumder PM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2727-2745. PubMed ID: 37987794
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in diabetic neuropathy.
Adki KM; Kulkarni YA
Arch Physiol Biochem; 2023 Apr; 129(2):460-475. PubMed ID: 33186087
[TBL] [Abstract][Full Text] [Related]
11. [Research progress of diabetic corneal neuropathy].
Xue JF; Dong YL; Zhou QJ; Xie LX
Zhonghua Yan Ke Za Zhi; 2021 Aug; 57(8):630-636. PubMed ID: 34344127
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets.
Dewanjee S; Das S; Das AK; Bhattacharjee N; Dihingia A; Dua TK; Kalita J; Manna P
Eur J Pharmacol; 2018 Aug; 833():472-523. PubMed ID: 29966615
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapies for diabetic neuropathy: a clinical overview.
Perkins BA; Bril V
Curr Diabetes Rev; 2005 Aug; 1(3):271-80. PubMed ID: 18220603
[TBL] [Abstract][Full Text] [Related]
15. Repurposing drugs targeting metabolic diseases for cancer therapeutics.
Pillai U J; Ray A; Maan M; Dutta M
Drug Discov Today; 2023 Sep; 28(9):103684. PubMed ID: 37379903
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy.
Sood A; Kumar B; Singh SK; Prashar P; Gautam A; Gulati M; Pandey NK; Melkani I; Awasthi A; Saraf SA; Vidari G; Ozdemir M; Hussain FHS; Anwar ET; Ameen MSM; Gupta S; Porwal O
Curr Pharm Des; 2020; 26(42):5468-5487. PubMed ID: 32851955
[TBL] [Abstract][Full Text] [Related]
17. [Elucidation and Application of Novel Action of Therapeutic Agents for Diabetic Neuropathy].
Sato K
Yakugaku Zasshi; 2022; 142(10):1037-1044. PubMed ID: 36184437
[TBL] [Abstract][Full Text] [Related]
18. Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.
Hussain N; Adrian TE
Curr Diabetes Rev; 2017; 13(5):488-497. PubMed ID: 27341846
[TBL] [Abstract][Full Text] [Related]
19. Current Strategies for the Management of Painful Diabetic Neuropathy.
Staudt MD; Prabhala T; Sheldon BL; Quaranta N; Zakher M; Bhullar R; Pilitsis JG; Argoff CE
J Diabetes Sci Technol; 2022 Mar; 16(2):341-352. PubMed ID: 32856490
[TBL] [Abstract][Full Text] [Related]
20. [Metabolomics in Diabetic Neuropathy].
Zhang Q; Song W; Liang XC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):313-317. PubMed ID: 35538768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
